Moreover, a recent preclinical study suggests that IL-21 can potentiate the ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to stimulate anti-tumor immunity in mice to resist bladder cancer (98). The gene discussed is CSF2; the disease is urinary bladder carcinoma.